Outcomes in systemic lupus erythematous (SLE) patients treated with belimumab in clinical practice settings: results from the observe study in switzerland

被引：0
|
作者：
von Kempis, J. [1 ]
Dutsch, S. [2 ]
Reuschling, N. [1 ]
Villiger, R. [3 ]
Vallelian, F. [4 ]
Schaer, D. J. [4 ]
Mueller, R. B. [1 ]
机构：
[1] Kantonsspital St Gallen, St Gallen, Switzerland
[2] GlaxoSmithKline AG, Munchenbuchsee, Switzerland
[3] Inselspital Bern, Bern, Switzerland
[4] Univ Spital Zurich, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2017年 / 147卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 3
引用
收藏
页码：4S / 4S
页数：1
相关论文
共 50 条
  • [1] OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOUS (SLE) PATIENTS TREATED WITH BELIMUMAB IN CLINICAL PRACTICE SETTINGS: RESULTS FROM THE OBSERVE STUDY IN GERMANY
    Schwarting, A.
    Koscielny, V. B.
    Carnarius, H.
    Cholmakow-Bodechtel, C.
    Alexander, T.
    Fiehn, C.
    Specker, C.
    Schmalzing, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 78 - 79
  • [2] Outcomes in systemic lupus erythematous (SLE) patients treated with belimumab: results from an observational study in Germany (OBSErve)
    Schwarting, A.
    Carnarius, H.
    Moore-Ramdin, L.
    Koscielny, V.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 141 - 141
  • [3] Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
    Johannes, von Kempis
    Sabine, Duetsch
    Nicola, Reuschling
    Rahel, Villiger
    Peter, Villiger M.
    Florencee, Vallelian
    Dominik, Schaer J.
    Ruediger, Mueller B.
    SWISS MEDICAL WEEKLY, 2019, 149
  • [4] Evolution of Patients with Systemic Lupus Erythematous Treated with Belimumab in Clinical Practice Settings
    Cortes, Josefina
    Marras, Carlos
    Luis Andreu, Jose
    Calvo-Alen, Jaime
    Garcia-Aparicio, Angel M.
    Diez Alvarez, Elvira
    Coronell, Carlos
    Morejon, Elena
    Perna, Alessandra
    Koscielny, Volker
    Ordi-Ros, Josep
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S291 - S292
  • [5] Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study
    Zahi Touma
    Amyn Sayani
    Christian A. Pineau
    Isabelle Fortin
    Mark Matsos
    George A. Ecker
    Andrew Chow
    Sandra Iczkovitz
    Rheumatology International, 2017, 37 : 865 - 873
  • [6] Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study
    Touma, Zahi
    Sayani, Amyn
    Pineau, Christian A.
    Fortin, Isabelle
    Matsos, Mark
    Ecker, George A.
    Chow, Andrew
    Iczkovitz, Sandra
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) : 865 - 873
  • [7] Disease Severity and Glucocorticoids Reduction in Systemic Lupus Erythematosus (SLE) Patients Receiving Belimumab in Clinical Practice Settings: Results from OBSErve Study in Canada
    Touma, Zahi
    Sayani, Amyn
    Iczkovitz, Sandra
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1194 - 1195
  • [8] 12-Month Outcomes Associated With Belimumab In Patients With Systemic Lupus Erythematosus In Clinical Practice Settings: The Observe Study
    Collins, Christopher E.
    Dall'Era, Maria
    Oglesby, Alan
    McGuire, Michael B.
    Pappu, Ramesh
    Kan, Hong
    Molta, Charles T.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S738 - S739
  • [9] OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOUS (SLE) PATIENTS WITH HIGH DISEASE ACTIVITY TREATED WITH BELIMUMAB: RESULTS FROM AN OBSERVATIONAL STUDY IN THE UNITED STATES (US)
    Kan, H.
    Collins, C.
    Dall'Era, M.
    McGuire, M. B.
    Koscielny, V.
    Pappu, R.
    Molta, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 253 - 254
  • [10] Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA
    Collins, C. E.
    Dall'Era, M.
    Kan, H.
    Macahilig, C.
    Molta, C.
    Koscielny, V.
    Chang, D. J.
    LUPUS SCIENCE & MEDICINE, 2016, 3 (01):
12345